Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma.
about
Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis.Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines.Improving melanoma classification by integrating genetic and morphologic featuresPrognostic and Clinicopathologic Associations of BRAF Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study.Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome.Melanoma molecular subtypes: unifying and paradoxical results.Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site.Association between BRAFV600E and NRASQ61R mutations and clinicopathologic characteristics, risk factors and clinical outcome of primary invasive cutaneous melanoma.Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.Dabrafenib and its potential for the treatment of metastatic melanoma.BRAF V600 mutations and pathological features in Japanese melanoma patients.Genetic and morphologic features for melanoma classificationBRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site.Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidenceThe melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas.Changes in the presentation of nodular and superficial spreading melanomas over 35 yearsThe molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.Histology-specific microRNA alterations in melanoma.BRAF kinase in melanoma development and progression.BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival.Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours.A review of transcriptomics in cutaneous chemical exposure.Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology.Testing the divergent pathway hypothesis for melanoma: recent findings and future challenges.Targeting BRAF for patients with melanoma.Malignant melanoma: from cell kinetics to micrometastases.BRAF mutation testing in clinical practice.Insights into melanoma: targeting the mTOR pathway for therapeutics.Vemurafenib for the treatment of melanoma.Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of BRAF mutations.Acneiform eruptions: a common cutaneous toxicity of the MEK inhibitor trametinib.Genetic alterations and personalized medicine in melanoma: progress and future prospects.BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions.Metastatic pathways in patients with cutaneous melanoma.Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.Associations of MC1R genotype and patient phenotypes with BRAF and NRAS mutations in melanoma.Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.
P2860
Q27851617-A907D0FC-57B8-4472-BBF1-4EEC2C318A40Q27852814-52564AB0-7940-4A2B-894D-79D4498E676BQ33340639-346884A8-0915-41DC-A5A3-8522F3A9ADD9Q33682137-765DE356-1DB0-45C2-BFF3-97F8CCF3C110Q33778554-7CD7C4B4-1262-449B-A310-66020BFD05C1Q34179210-B36F898E-2D52-449C-AC45-F1F5AA05AEC7Q34446657-5CA2BC8E-1595-4146-837B-3625091F1F50Q34454042-CBD0E8C1-B126-4052-8282-1F29BAB90374Q34633885-2867F514-424F-4C63-A730-3F9524CDB498Q34646614-27F6BEEA-3EAE-4292-9E16-D15D55B398E7Q34772719-1F014807-A7BF-4D23-A1F1-27F41ADC43EEQ35024226-AB7EB1E1-41E1-4764-AF75-67C1E9E2F56AQ35024230-D434A449-1532-49B6-85CA-0B5218473F24Q35801085-962492F8-9FB9-45B0-9C07-C2DB466232E3Q35810176-E3B69C0D-9D8A-4612-A1DC-AF5CEE02E37DQ36092451-0827E8C0-38C3-428B-9012-F3B74ACC342EQ36343518-DD15BDED-5CF4-4915-AD93-174CC515884DQ36759522-36C3CB26-293F-4FEF-9D67-78263EB0976FQ36798179-152F279A-28A7-41CB-A1BA-2B988D2F06E9Q36828567-CFE33028-9139-4A2C-9629-88A2FD7C5602Q37086193-77F0C387-1689-440D-B9CE-5E3825549B5BQ37174935-9DC1C913-6D72-47F8-ACE2-E29BAA615C84Q37389151-313E899E-643B-430C-BE40-C89FE3F6F298Q37627265-1B21D966-2668-4EC2-9A4F-D4D41B53DFDFQ37707106-05B4A5E6-F20C-43E6-8D30-453118960D7DQ37752347-80F7E177-C811-447F-92C0-7B40B5F65A94Q37817713-A074B160-069E-41D8-B022-82788CDFB7E9Q37818162-4106F5F7-115A-4FD2-A0A3-5FE76A0DD33DQ37988572-314E92AE-3DF8-48BF-B310-731EBB7C44D9Q38012466-E2F727BE-9175-4104-9A9F-EE1701603F34Q38055208-DC7223D6-5885-4C99-9324-EB791F8785F0Q38081987-B40A5342-15E8-4792-9AB8-121DE5B6DCF9Q38169253-77CF617A-9C99-4696-B536-417A7AE4353FQ38186704-8861C4A9-43C8-42F8-97DA-E819C24C0568Q38381486-9D05D65C-3EAE-4795-BDCE-A2A9616D7EF5Q39024316-2BBA9411-37F6-435E-BB54-69C9C11A1719Q39756781-A6FDB039-3486-4247-AF73-78B41FC2EB2CQ40069925-1F63367C-6524-4CD1-A154-B339AA7E5E2EQ40087210-2913F185-6715-4E2D-A7EE-B522FE2CC67BQ40630464-2A99FC3C-F975-4A79-B0AF-7594BCD02DA0
P2860
Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Distinct clinical and patholog ...... mutation in primary melanoma.
@ast
Distinct clinical and patholog ...... mutation in primary melanoma.
@en
type
label
Distinct clinical and patholog ...... mutation in primary melanoma.
@ast
Distinct clinical and patholog ...... mutation in primary melanoma.
@en
prefLabel
Distinct clinical and patholog ...... mutation in primary melanoma.
@ast
Distinct clinical and patholog ...... mutation in primary melanoma.
@en
P2093
P50
P356
P1476
Distinct clinical and patholog ...... mutation in primary melanoma.
@en
P2093
Christopher Angel
Graham Mason
Jill Magee
John P Dowling
John W Kelly
Melanie Trivett
William K Murray
P2888
P304
P356
10.1038/SJ.JID.5700632
P407
P577
2006-12-07T00:00:00Z
P5875
P6179
1009772826